semaglutide and bowel issues Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Does Ozempic Cause Gastroparesis? [2026

doi: 10.1038/s41388-022-02312-y 85 WeiYJianwenHQichaoDWentingLLeiJQianZet al

In the nearer term, companies are developing oral care products specifically for the GLP-1 medication population

By engineering an analog that binds these proteins poorly, researchers created a form of IGF-1 that remains largely free and therefore available to engage the IGF-1 receptor over a much longer window

Notably, the manufacturer has filed with the FDA for a second indication to reduce MACE in adults with T2D and established cardiovascular disease

These types of medications can help manage blood sugar levels, however early research is showing GLP-1 and anesthesia can create adverse complications for the patient